← All sarcoma trials
Recruiting nowAll ages

An Organoid-based Functional Precision Medicine Trial in Osteosarcoma

Sponsor: Jonsson Comprehensive Cancer Center · NCT06064682 on ClinicalTrials.gov ↗

Conditions studied

Osteosarcoma

What it tests

  • standard of care biopsyother
  • standard of care biopsyother

Where it's running1 site

See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion / exclusion criteria - Group1:

\- Patients without diagnosis of osteosarcoma and whose imaging studies are suggestive of osteosarcoma and who are planned to undergo biopsy or surgery for diagnostic purposes

Inclusion / exclusion criteria - Group 2:

\- Patients whose imaging studies are suggestive of metastatic osteosarcoma and who are planned to undergo biopsy or surgery for diagnostic purposes

Updated 2026-05-11 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.